Predictors of the use of medications before and during pregnancy

被引:20
|
作者
Odalovic, Marina [1 ]
Kovacevic, Sandra Vezmar [2 ]
Nordeng, Hedvig [3 ]
Ilic, Katarina [4 ]
Sabo, Ana [5 ]
Tasic, Ljiljana [1 ]
机构
[1] Univ Belgrade, Fac Pharm, Dept Social Pharm & Pharmaceut Legislat, Belgrade 11221, Serbia
[2] Univ Belgrade, Fac Pharm, Dept Pharmacokinet & Clin Pharm, Belgrade 11221, Serbia
[3] Univ Oslo, Sch Pharm, Dept Pharm, N-0316 Oslo, Norway
[4] Univ Belgrade, Fac Pharm, Dept Pharmacol, Belgrade 11221, Serbia
[5] Univ Novi Sad, Dept Pharmacol Toxicol & Clin Pharmacol, Fac Med, Novi Sad 21000, Serbia
关键词
Maternal health; Medication use; Pregnancy; Serbia; Socio-economic factors; PRESCRIPTION DRUG-USE; OVER-THE-COUNTER; COHORT; PREVALENCE; LACTATION; PATTERNS; MOTHERS;
D O I
10.1007/s11096-013-9750-7
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background Drug use in pregnancy is often reason of concern for mothers and their physicians. However, only few studies investigated predictors of drug use in pregnancy. Objectives To examine maternal characteristics as predictors of medication use in the 6 months before pregnancy and during the first 6 months of pregnancy. To examine whether prescription and over-the-counter (OTC) medication use in the 6 months before pregnancy had an impact on medication use in pregnancy. Setting Six maternity care units and five community pharmacies. Method Data were collected using a specially designed self-reported questionnaire during the period March 2009-March 2010. Logistic regression was used to identify factors associated with medication use. Main outcome measure Adjusted odds ratios (aOR) and 95 % confidence intervals (CI) were used as association measures. Results A total of 236 women were included in the analysis. After controlling for maternal characteristics, parity of more than one was associated with lower prescription medication use in pregnancy (aOR 0.46; 95 % CI 0.22-0.93), higher household income with higher OTC medication use before pregnancy (aOR 3.13; 95 % CI 1.22-8.00), and miscarriage with higher C and D Food and Drug Administration (FDA) risk category medication use in pregnancy (aOR 3.65; 95 % CI 1.30-10.25). Prescription medication use before pregnancy was associated with higher prescription medication use in pregnancy (aOR 2.49; 95 % CI 1.12-5.52), OTC medication use before pregnancy with higher OTC medication use in pregnancy (aOR 35.95; 95 % CI 7.95-162.49), and C and D FDA risk category medication use before pregnancy with the same category medication use in pregnancy (aOR 3.54; 95 % CI 1.23-10.17). Conclusion Different maternal characteristics were shown as predictors of medication use before and during pregnancy. However, medication use before pregnancy was shown as the most important predicting factor for the medication use in pregnancy.
引用
收藏
页码:408 / 416
页数:9
相关论文
共 50 条
  • [1] Predictors of the use of medications before and during pregnancy
    Marina Odalovic
    Sandra Vezmar Kovacevic
    Hedvig Nordeng
    Katarina Ilic
    Ana Sabo
    Ljiljana Tasic
    [J]. International Journal of Clinical Pharmacy, 2013, 35 : 408 - 416
  • [2] Alcohol and Drug Use Before and During Pregnancy: An Examination of Use Patterns and Predictors of Cessation
    Harrison, Patricia A.
    Sidebottom, Abbey C.
    [J]. MATERNAL AND CHILD HEALTH JOURNAL, 2009, 13 (03) : 386 - 394
  • [3] Alcohol and Drug Use Before and During Pregnancy: An Examination of Use Patterns and Predictors of Cessation
    Patricia A. Harrison
    Abbey C. Sidebottom
    [J]. Maternal and Child Health Journal, 2009, 13
  • [4] Prevalence of alcohol use before and during pregnancy and predictors of drinking during pregnancy: a cross sectional study in Sweden
    Janna Skagerström
    Siw Alehagen
    Elisabet Häggström-Nordin
    Kristofer Årestedt
    Per Nilsen
    [J]. BMC Public Health, 13
  • [5] Prevalence of alcohol use before and during pregnancy and predictors of drinking during pregnancy: a cross sectional study in Sweden
    Skagerstrom, Janna
    Alehagen, Siw
    Haggstrom-Nordin, Elisabet
    Arestedt, Kristofer
    Nilsen, Per
    [J]. BMC PUBLIC HEALTH, 2013, 13
  • [6] Use of Tamoxifen Before and During Pregnancy
    Braems, Geert
    Denys, Hannelore
    De Wever, Olivier
    Cocquyt, Veronique
    Van den Broecke, Rudy
    [J]. ONCOLOGIST, 2011, 16 (11): : 1547 - 1551
  • [7] Herbal use before and during pregnancy
    Broussard, Cheryl S.
    Louik, Carol
    Honein, Margaret A.
    Mitchell, Allen A.
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2010, 202 (05) : 443.e1 - 443.e6
  • [8] The use of newer asthma and allergy medications during pregnancy
    Callaghan, ML
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2000, 84 (05) : 475 - 480
  • [9] Use of over-the-counter medications during pregnancy
    Tillett, J
    Kostich, LM
    VandeVusse, L
    [J]. JOURNAL OF PERINATAL & NEONATAL NURSING, 2003, 17 (01) : 3 - 18
  • [10] Prevalence and Use of Medications for Autoimmune Diseases during Pregnancy
    Mainbourg, S.
    Sheehy, O.
    Vinet, E.
    Berard, A.
    [J]. BIRTH DEFECTS RESEARCH, 2023, 115 (08): : 888 - 888